Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    Open Studies | "Aspergillosis, Allergic Bronchopulmonary"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Aspergillosis, Allergic Bronchopulmonary" (7 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis;   A. Fumigatus
Intervention: Dietary Supplement: cholecalciferol (Vitamin D3)
2 Unknown  Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Intervention:
3 Recruiting Protocol TARC-ABPA
Condition: Allergic Broncho-Pulmonary Aspergillosis
Intervention: Other: Study of predictive factors
4 Recruiting Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Prednisolone;   Drug: Voriconazole
5 Unknown  Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Glucocorticoids
6 Recruiting A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Inhaled budesonide;   Drug: Inhaled amphotericin
7 Not yet recruiting Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Liposomal amphotericin B (Ambisome®)

Indicates status has not been verified in more than two years